Showing results (31-40 of 179) with videos related to
Sort By:
Pageof 18
Human Pathology|March 10, 2012
CD70 expression patterns in renal cell carcinomaLucia B Jilaveanu, Joshua Sznol, Saadia A Aziz, et al.Current Opinion in Neurology|October 3, 2019
Complications associated with immunotherapy for brain metastasesThuy T Tran, Lucia B Jilaveanu, Antonio Omuro, et al.Biomed Research International|October 9, 2015
MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway InhibitorsBrian Shuch, Ryan Falbo, Fabio Parisi, et al.American Journal of Clinical Oncology|August 25, 2021
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain MetastasesHaruka Uezono, David Nam, Harriet M Kluger, et al.Cancer Research|December 18, 2003
Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survivalAaron J Berger, Harriet M Kluger, Ning Li, et al.Cancer Research|September 7, 2007
Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancerKenneth D Bromberg, Harriet M Kluger, Agnes Delaunay, et al.Cancer Research|December 3, 2004
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcomeAaron J Berger, Robert L Camp, Kyle A Divito, et al.Frontiers in Endocrinology|November 24, 2025
Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patientsNoam Savion Gaiger, Michael E Hurwitz, Navid Hafez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysisHarriet M Kluger, Marisa Dolled-Filhart, Sofya Rodov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancerMary M McCarthy, Mario Sznol, Kyle A DiVito, et al.Pageof 18